TipRanks
Haemonetics Corp. (HAE)
NYSE:HAE
US Market
HAE
Haemonetics
RESEARCH TOOLSreports
Want to see HAE full AI Analyst Report?

Haemonetics (HAE) Ratios

440 Followers

Haemonetics Ratios

HAE's free cash flow for Q1 2027 was $0.60. For the 2027 fiscal year, HAE's free cash flow was decreased by $ and operating cash flow was $0.14. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 3.08 2.95 1.62 2.56 3.06
Quick Ratio
 1.91 1.87 0.99 1.50 2.03
Cash Ratio
 0.85 0.87 0.53 0.60 1.13
Solvency Ratio
 0.14 0.16 0.17 0.17 0.18
Operating Cash Flow Ratio
 1.25 1.04 0.31 0.61 1.08
Short-Term Operating Cash Flow Coverage
 66.21 58.47 0.60 17.77 23.17
Net Current Asset Value
$ -717.47M$ -764.73M$ -695.14M$ -466.73M$ -347.11M
Leverage Ratios
Debt-to-Assets Ratio
 0.50 0.51 0.50 0.37 0.40
Debt-to-Equity Ratio
 1.40 1.54 1.49 0.84 0.94
Debt-to-Capital Ratio
 0.58 0.61 0.60 0.46 0.48
Long-Term Debt-to-Capital Ratio
 0.58 0.60 0.53 0.45 0.48
Financial Leverage Ratio
 2.83 3.01 2.99 2.29 2.37
Debt Service Coverage Ratio
 6.39 8.36 0.99 11.23 8.56
Interest Coverage Ratio
 8.03 8.41 22.76 12.67 10.67
Debt to Market Cap
 0.24 0.48 0.39 0.19 0.18
Interest Debt Per Share
 26.56 26.56 24.53 16.19 15.37
Net Debt to EBITDA
 3.64 3.13 2.58 2.13 1.91
Profitability Margins
Gross Profit Margin
57.38%55.74%57.21%54.38%53.30%
EBIT Margin
11.18%11.75%18.16%15.80%14.31%
EBITDA Margin
19.32%23.42%26.16%22.57%21.56%
Operating Profit Margin
18.18%18.10%16.30%12.60%13.35%
Pretax Profit Margin
9.65%9.60%15.58%11.60%12.10%
Net Profit Margin
7.12%7.29%12.32%8.98%9.87%
Continuous Operations Profit Margin
7.12%7.29%12.32%8.98%9.87%
Net Income Per EBT
73.82%76.00%79.07%77.41%81.61%
EBT Per EBIT
53.08%53.04%95.61%92.10%90.62%
Return on Assets (ROA)
4.07%4.06%6.84%5.35%5.96%
Return on Equity (ROE)
11.35%12.22%20.43%12.25%14.11%
Return on Capital Employed (ROCE)
11.69%11.42%11.84%8.70%9.27%
Return on Invested Capital (ROIC)
8.61%8.66%8.06%6.70%7.51%
Return on Tangible Assets
7.56%7.53%12.06%9.60%9.67%
Earnings Yield
2.00%3.82%5.27%2.73%2.75%
Efficiency Ratios
Receivables Turnover
 6.26 6.15 6.71 6.34 6.52
Payables Turnover
 10.23 11.56 8.69 8.14 8.54
Inventory Turnover
 1.88 1.93 1.59 1.88 2.10
Fixed Asset Turnover
 4.45 4.36 4.79 3.57 3.76
Asset Turnover
 0.57 0.56 0.56 0.60 0.60
Working Capital Turnover Ratio
 2.46 2.93 3.30 2.65 2.81
Cash Conversion Cycle
 216.96 217.16 241.25 206.64 186.66
Days of Sales Outstanding
 58.33 59.33 54.36 57.60 55.95
Days of Inventory Outstanding
 194.32 189.39 228.89 193.89 173.46
Days of Payables Outstanding
 35.69 31.56 42.00 44.84 42.75
Operating Cycle
 252.65 248.73 283.24 251.48 229.41
Cash Flow Ratios
Operating Cash Flow Per Share
 7.23 6.22 3.61 3.58 5.38
Free Cash Flow Per Share
 6.42 5.52 2.83 2.28 3.21
CapEx Per Share
 0.81 0.69 0.78 1.31 2.17
Free Cash Flow to Operating Cash Flow
 0.89 0.89 0.78 0.64 0.60
Dividend Paid and CapEx Coverage Ratio
 8.89 8.95 4.63 2.74 2.48
Capital Expenditure Coverage Ratio
 8.89 8.95 4.63 2.74 2.48
Operating Cash Flow Coverage Ratio
 0.28 0.24 0.15 0.22 0.36
Operating Cash Flow to Sales Ratio
 0.24 0.22 0.13 0.14 0.23
Free Cash Flow Yield
6.03%10.22%4.48%2.69%3.88%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 51.55 26.36 19.09 36.57 36.41
Price-to-Sales (P/S) Ratio
 3.57 1.91 2.34 3.28 3.60
Price-to-Book (P/B) Ratio
 5.75 3.20 3.87 4.48 5.14
Price-to-Free Cash Flow (P/FCF) Ratio
 16.57 9.79 22.33 37.24 25.80
Price-to-Operating Cash Flow Ratio
 14.68 8.69 17.50 23.66 15.39
Price-to-Earnings Growth (PEG) Ratio
 -1.38 -0.69 0.45 16.60 0.22
Price-to-Fair Value
 5.75 3.20 3.87 4.48 5.14
Enterprise Value Multiple
 22.12 11.29 11.51 16.68 18.59
Enterprise Value
 5.78B 3.53B 4.10B 4.93B 4.68B
EV to EBITDA
 22.12 11.29 11.51 16.68 18.59
EV to Sales
 4.27 2.65 3.01 3.76 4.01
EV to Free Cash Flow
 19.84 13.55 28.77 42.69 28.76
EV to Operating Cash Flow
 17.61 12.03 22.55 27.12 17.15
Tangible Book Value Per Share
 -5.61 -6.52 -4.75 -0.22 1.50
Shareholders’ Equity Per Share
 18.45 16.88 16.31 18.93 16.11
Tax and Other Ratios
Effective Tax Rate
 0.26 0.24 0.21 0.23 0.18
Revenue Per Share
 29.81 28.28 27.04 25.82 23.01
Net Income Per Share
 2.12 2.06 3.33 2.32 2.27
Tax Burden
 0.74 0.76 0.79 0.77 0.82
Interest Burden
 0.86 0.82 0.86 0.73 0.85
Research & Development to Revenue
 0.04 0.04 0.05 0.05 0.05
SG&A to Revenue
 0.33 0.33 0.31 0.32 0.31
Stock-Based Compensation to Revenue
 0.03 0.03 0.02 0.02 0.02
Income Quality
 3.41 3.01 1.08 1.55 2.37
Currency in USD